Results 151 to 160 of about 2,702 (213)

Emergence of red blood cell alloantibodies and transfusion management in patients with warm autoantibodies at a tertiary care centre in British Columbia, Canada

Vox Sanguinis, Volume 121, Issue 3, Page 339-344, March 2026.
Abstract Background and Objectives The presence of warm autoantibodies (WAAs) complicates pre‐transfusion and compatibility testing. Despite attempts to provide antigen‐matched red blood cells (RBCs), the risk of alloimmunization remains. Rates of alloimmunization and indications for transfusion were reviewed to streamline testing and RBC provision ...
S. Hutspardol, J. Mi, C. Denesiuk, D. Kalar, L. Sham, M. Roche, J. R. Tsu, D. Lam, M. T. S. Yan   +8 more
wiley   +1 more source

Co-Induction of ULK-1 and AHSP mRNAs in Erythroid Precursor Cells Isolated From a Sirolimus-Treated β-Thalassemia Patient: A Case Report Study. [PDF]

Br J Biomed Sci
Zurlo M, Finotti A, Gamberini MR, Gambari R.   +3 more
europepmc   +1 more source

Evaluating compliance with restrictive blood transfusion practices: A 5‐year study from a Greek tertiary hospital

Vox Sanguinis, Volume 121, Issue 3, Page 322-330, March 2026.
Abstract Background and Objectives Our aim was to retrospectively assess the adherence to a restrictive transfusion strategy (in the context of patient blood management [PBM]) among patients in a Greek tertiary hospital over a 5‐year period (2020–2024) following the initial evaluation of the electronic transfusion request system.
Georgios K. Nikolopoulos, Athena Koutoulogeni, Elias Kyriakou, Stavros Tsalas, Anastasia Papandreadi, Panagiota Douramani, Styliani I. Kokoris, Electra Loukopoulou, Aimilia Tsante, Athina Kypraiou, Aristarchos Poulis, Stefanos Bonovas, Anastasios Kriebardis, Argirios E. Tsantes   +13 more
wiley   +1 more source

Development of an ELISA strip for the detection of α thalassemias

Haematologica, 2010
Luksana Makonkawkeyoon, Somphon Pharephan, Pannee Sirivatanapa, Wirote Tuntiwechapikul, Sanit Makonkawkeyoon   +4 more
doaj   +1 more source

The Relevance of β-Thalassemia Heterozygosity in Pediatric Clinical Practice: Croatian Experience. [PDF]

Children (Basel)
Dordevic A, Ugrin M, Sutic IM, Roganovic J, Pavlovic S.   +4 more
europepmc   +1 more source

Editorial: Micro-nano-materials for drug delivery, disease diagnosis, and therapeutic treatment. [PDF]

Front Bioeng Biotechnol
Guo B, Peng T, Mi C, Ye L.
europepmc   +1 more source

Luspatercept Treatment in a β-Thalassemia Patient with Pulmonary Arterial Hypertension: A Case Report. [PDF]

Mediterr J Hematol Infect Dis
Yang B, Liu D, Yang C, Zhou Y, Liao G, Huang J, Li Y, Tang Y, Yin X.   +8 more
europepmc   +1 more source

Hemoglobin Variants as Targets for Stabilizing Drugs. [PDF]

Molecules
Žoldáková M, Novotný M, Khakurel KP, Žoldák G.   +3 more
europepmc   +1 more source

Novel Red Blood Cell Exchange Parameters for Treatment of Transfusion-Dependent Thalassemia Based on Experience of Five Patients. [PDF]

J Hematol
Sevcik K, Jackson C, Williams SM, Koepsell SA, Bobr A.   +4 more
europepmc   +1 more source

Analysis of genotypic distribution and rare variants of patients with α/β-thalassemia screened in one hospital in Beijing, China. [PDF]

Hum Genomics
Zhang H, Wang Z, Yang Z, Chen X, Xu H, Zeng X, Yu Q, Kong L, Zhang R, Yi J, Wu J, Gan Y, Chen Y, Ye A, Wang Z, Zhang D, Han X, Du J, Dou Y.   +18 more
europepmc   +1 more source